A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
A phase 1/2 trial of Pemetrexed, Paclitaxel / nab-paclitaxel, Carboplatin in endometrial cancer, run by Huabo Biopharm Co., Ltd., now recruiting.
Overview
A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor is a phase 1/2 interventional study registered as NCT06758557 by Huabo Biopharm Co., Ltd., with 282 participants planned, started 2024-01-31 and due to reach its primary completion in 2025-10-31. Interventions recorded: HB0025, Pemetrexed, Paclitaxel, Carboplatin. Conditions listed: Advanced NSCLC, Advanced Endometrial Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialIPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Shares Pemetrexed, Paclitaxel / nab-paclitaxel, Carboplatin.
- TrialA Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
Shares Paclitaxel / nab-paclitaxel, Endometrial cancer, Carboplatin.
- TrialA Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Shares Pemetrexed, Carboplatin.
- TrialA Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung
Shares Pemetrexed, Paclitaxel / nab-paclitaxel, Carboplatin.
- TrialCATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ov
Shares Paclitaxel / nab-paclitaxel, Carboplatin.
- TrialVolrustomig Priming Regimens Exploratory Phase II Platform Study
Shares Pemetrexed, Paclitaxel / nab-paclitaxel, Carboplatin.
- TrialStudy of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Shares Pemetrexed, Carboplatin.
- TrialStudy of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
Shares Pemetrexed, Carboplatin.